Listen Live

Current Weather

Loading advertisement…

Kardigan surges in Nasdaq debut after upsized $400 million IPO

By Aditi Tiwari and Prakhar Srivastava June 18 (Reuters) - Kardigan's shares rose 31% above their initial public offering price on Thursday after the heart drug developer raised $400 million in an upsized U.S. initial public offering, signaling strong investor appetite for new biotech listings.... Read More.